Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$23.12
+6.3%
$20.35
$17.86
$29.62
$1.13B1.97402,399 shs530,334 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$124.87
+6.1%
$121.56
$112.31
$212.00
$4.10B1.33633,476 shs704,709 shs
Liquidia Corporation stock logo
LQDA
Liquidia
$42.28
+0.3%
$36.79
$11.85
$46.67
$3.76B0.411.63 million shs1.20 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$72.90
0.0%
$114.04
$70.00
$156.00
$2.52B2.07998,878 shs2.65 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+0.93%+8.80%+12.87%-1.23%-0.83%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-0.35%-2.53%+0.41%-19.80%-12.88%
Liquidia Corporation stock logo
LQDA
Liquidia
+5.01%+10.46%+11.93%+1.40%+170.60%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-23.19%-26.02%-30.42%-43.73%-21.91%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$23.12
+6.3%
$20.35
$17.86
$29.62
$1.13B1.97402,399 shs530,334 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$124.87
+6.1%
$121.56
$112.31
$212.00
$4.10B1.33633,476 shs704,709 shs
Liquidia Corporation stock logo
LQDA
Liquidia
$42.28
+0.3%
$36.79
$11.85
$46.67
$3.76B0.411.63 million shs1.20 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$72.90
0.0%
$114.04
$70.00
$156.00
$2.52B2.07998,878 shs2.65 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+0.93%+8.80%+12.87%-1.23%-0.83%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-0.35%-2.53%+0.41%-19.80%-12.88%
Liquidia Corporation stock logo
LQDA
Liquidia
+5.01%+10.46%+11.93%+1.40%+170.60%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-23.19%-26.02%-30.42%-43.73%-21.91%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.80
Moderate Buy$32.0038.41% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.93
Moderate Buy$193.3854.87% Upside
Liquidia Corporation stock logo
LQDA
Liquidia
2.92
Moderate Buy$43.442.75% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.50
Moderate Buy$135.0085.19% Upside

Current Analyst Ratings Breakdown

Latest BLFS, IRTC, TMDX, and LQDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$152.00 ➝ $124.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$190.00 ➝ $120.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetHold$130.00 ➝ $85.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetOverweight$160.00 ➝ $120.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$174.00 ➝ $142.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
DowngradeOutperformMarket Perform
5/5/2026
Liquidia Corporation stock logo
LQDA
Liquidia
UpgradeHoldStrong-Buy
5/4/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Boost Price TargetBuy$155.00 ➝ $157.00
5/1/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$198.00 ➝ $180.00
5/1/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$215.00 ➝ $175.00
5/1/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$200.00 ➝ $180.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M11.75$0.25 per share94.11$7.72 per share2.99
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M5.49N/AN/A$4.91 per share25.43
Liquidia Corporation stock logo
LQDA
Liquidia
$158.32M23.74N/AN/A$0.51 per share82.90
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M4.16$3.02 per share24.17$13.79 per share5.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M-$0.11N/A92.48N/A-4.50%1.71%1.54%5/7/2026 (Estimated)
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.86N/A95.32N/A-3.53%-10.26%-1.39%N/A
Liquidia Corporation stock logo
LQDA
Liquidia
-$68.92M-$0.83N/A14.53N/A-43.53%-209.33%-25.32%5/11/2026 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$4.9016.5719.03N/A27.04%24.01%9.48%N/A

Latest BLFS, IRTC, TMDX, and LQDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Liquidia Corporation stock logo
LQDA
Liquidia
$0.34N/AN/AN/A$116.62 millionN/A
5/7/2026Q1 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.01$0.02+$0.01$0.02$25.66 million$27.50 million
5/5/2026Q1 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.62$0.30-$0.32$0.20$174.44 million$173.93 million
4/30/2026Q1 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million
3/18/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.01$0.15+$0.14N/AN/AN/A
3/5/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.08$0.15+$0.07$0.15$87.49 million$92.02 million
2/19/2026Q4 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$0.02$0.29+$0.27$0.17$202.61 million$208.89 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Liquidia Corporation stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
5.94
4.63
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
4.03
5.17
4.98
Liquidia Corporation stock logo
LQDA
Liquidia
2.97
2.01
1.84
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.06
7.14
6.59

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Liquidia Corporation stock logo
LQDA
Liquidia
64.54%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Liquidia Corporation stock logo
LQDA
Liquidia
25.60%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.90 million47.82 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.86 million32.54 millionOptionable
Liquidia Corporation stock logo
LQDA
Liquidia
5088.89 million66.14 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.53 million32.15 millionOptionable

Recent News About These Companies

TransMedics Group Stock Watch: Healthcare Growth in Focus
TransMedics tumbles after earnings miss
TransMedics: Cheaper, But Still Priced For Perfection
TransMedics Group Q1 Earnings Call Highlights
TransMedics: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$23.12 +1.37 (+6.30%)
Closing price 04:00 PM Eastern
Extended Trading
$23.10 -0.02 (-0.06%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$124.87 +7.17 (+6.09%)
Closing price 04:00 PM Eastern
Extended Trading
$124.94 +0.07 (+0.06%)
As of 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Liquidia stock logo

Liquidia NASDAQ:LQDA

$42.28 +0.14 (+0.33%)
Closing price 04:00 PM Eastern
Extended Trading
$42.08 -0.20 (-0.47%)
As of 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$72.90 -0.02 (-0.03%)
Closing price 04:00 PM Eastern
Extended Trading
$72.80 -0.10 (-0.14%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.